Population pharmacokinetic modeling and simulation to guide dose selection for RBP-7000, a new sustained-release formulation of risperidone

Dose Selection ◽

Release Formulation ◽

Sustained Release Formulation ◽

Selection For ◽

P.0461 Population pharmacokinetic modeling and simulation to guide dose selection for TV-46000, a new long-acting formulation of risperidone for subcutaneous injection

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2021.10.434 ◽

2021 ◽

Vol 53 ◽

pp. S338

Author(s):

I. Perlstein ◽

A. Merenlender Wagner ◽

M. Lamson ◽

O. Spiegelstein ◽

P. Loupe ◽

...

Keyword(s):

Modeling And Simulation ◽

Subcutaneous Injection ◽

Dose Selection ◽

Selection For ◽

Long Acting ◽

Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder

The Journal of Clinical Pharmacology ◽

10.1002/jcph.665 ◽

2016 ◽

Vol 56 (7) ◽

pp. 806-815 ◽

Cited By ~ 19

Author(s):

Celine M. Laffont ◽

Roberto Gomeni ◽

Christian Heidbreder ◽

J. P. Jones ◽

Azmi F. Nasser

Keyword(s):

Sustained Release ◽

Opioid Use Disorder ◽

Opioid Use ◽

Release Formulation ◽

Sustained Release Formulation ◽

Repeated Administrations ◽

Long Acting

Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study

Clinical Pharmacokinetics ◽

10.1007/s40262-021-01035-9 ◽

2021 ◽

Author(s):

Stan J. F. Hartman ◽

Parth J. Upadhyay ◽

Nienke N. Hagedoorn ◽

Ron A. A. Mathôt ◽

Henriëtte A. Moll ◽

...

Keyword(s):

Modeling And Simulation ◽

Critically Ill ◽

Simulation Study ◽

Critically Ill Children ◽

Dose Recommendations ◽

Population pharmacokinetic modeling and simulation of HPPH in Chinese patients with esophageal carcinoma

Xenobiotica ◽

10.1080/00498254.2019.1597315 ◽

2019 ◽

Vol 50 (2) ◽

pp. 180-187

Author(s):

Lin Chen ◽

Xuxiao Ye ◽

Kuan Hu ◽

Yu Zhai ◽

Wenping Li ◽

...

Keyword(s):

Esophageal Carcinoma ◽

Modeling And Simulation ◽

Chinese Patients ◽

Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases

International Immunopharmacology ◽

10.1016/j.intimp.2019.03.034 ◽

2019 ◽

Vol 71 ◽

pp. 404-410 ◽

Cited By ~ 2

Author(s):

Todd Dumas ◽

N. Seth Berry ◽

Martin Wolfsegger ◽

Stephen Jolles ◽

Barbara McCoy ◽

...

Keyword(s):

Modeling And Simulation ◽

Primary Immunodeficiency ◽

Subcutaneous Immunoglobulin ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Dosing Intervals ◽

Population pharmacokinetic modeling and simulation of huperzine A in elderly Chinese subjects

Acta Pharmacologica Sinica ◽

10.1038/aps.2016.24 ◽

2016 ◽

Vol 37 (7) ◽

pp. 994-1001 ◽

Cited By ~ 2

Author(s):

Lei Sheng ◽

Yi Qu ◽

Jing Yan ◽

Gang-yi Liu ◽

Wei-liang Wang ◽

...

Keyword(s):

Modeling And Simulation ◽

Huperzine A ◽

Elderly Chinese ◽

Chinese Subjects ◽

Population pharmacokinetic modeling and simulation of amprenavir following fosamprenavir/ritonavir administration for dose optimization in HIV infected pediatric patients

The Journal of Clinical Pharmacology ◽

10.1002/jcph.205 ◽

2013 ◽

Vol 54 (2) ◽

pp. 206-214 ◽

Cited By ~ 3

Author(s):

April M. Barbour ◽

Leonid Gibiansky ◽

Mary Beth Wire

Keyword(s):

Modeling And Simulation ◽

Pediatric Patients ◽

Dose Optimization ◽

Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data

CNS Drugs ◽

10.1007/s40263-017-0416-1 ◽

2017 ◽

Vol 31 (4) ◽

pp. 273-288 ◽

Cited By ~ 8

Author(s):

Mats O. Magnusson ◽

Mahesh N. Samtani ◽

Elodie L. Plan ◽

E. Niclas Jonsson ◽

Stefaan Rossenu ◽

...

Keyword(s):

Clinical Trial ◽

Modeling And Simulation ◽

Clinical Trial Data ◽

Trial Data ◽

Paliperidone Palmitate ◽

Switching Strategies ◽

Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and Simulation

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.983 ◽

2018 ◽

Vol 104 (3) ◽

pp. 564-574 ◽

Cited By ~ 23

Author(s):

Shelby Barnett ◽

Kayode Ogungbenro ◽

Karelle Ménochet ◽

Hong Shen ◽

Yurong Lai ◽

...

Keyword(s):

Drug Interactions ◽

Modeling And Simulation ◽

Mechanistic Insight ◽

Insight Into ◽

Coproporphyrin I ◽

025 Population Pharmacokinetic Modeling and Simulation to Assess the Impact of an 8 Week Maintenance Dosing Regimen for Intramuscular Testosterone Undecanoate

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2021.01.095 ◽

2021 ◽

Vol 18 (3) ◽

pp. S15

Author(s):

A. Pastuszak ◽

M. Bush ◽

L. Curd ◽

S. Vijayan ◽

T. Priestley ◽

...

Keyword(s):

Modeling And Simulation ◽

Dosing Regimen ◽

Testosterone Undecanoate ◽

The Impact ◽